Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

116
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Types of Reports II: Incident or Occurrence Report01:21

Types of Reports II: Incident or Occurrence Report

1.3K
An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
1.3K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

229
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229
Hazard Ratio01:12

Hazard Ratio

756
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
756
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EV-103 dose escalation/cohort A: 5-year follow-up of enfortumab vedotin plus pembrolizumab in previously untreated locally advanced/metastatic urothelial carcinoma.

ESMO openยท2026
Same author

First sub-MeV nuclear reaction measurements in a heavy-ion storage ring.

The European physical journal. A, Hadrons and nucleiยท2026
Same author

Measurement of the <sup>235</sup>U fission cross section relative to the standard <sup>10</sup>B(n, ฮฑ) reaction at the CERN n_TOF facility: Results for E<sub>n</sub>< 2 eV.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicineยท2025
Same author

Neutron capture measurements for s-process nucleosynthesis: A review about CERN n_TOF developments and contributions.

The European physical journal. A, Hadrons and nucleiยท2025
Same author

The P4 study: Subsequent pregnancy maternal physiology after hypertensive and normotensive pregnancies.

Pregnancy hypertensionยท2021
Same author

Introduction of paediatric laparoscopic cholecystectomy in Scotland: a national review of incidence, outcomes and training implications.

Scottish medical journalยท2021
Same journal

New bovine TB strategy for England.

The Veterinary recordยท2026
Same journal

BVA Scottish Branch's next president.

The Veterinary recordยท2026
Same journal

Meet your BVA team.

The Veterinary recordยท2026
Same journal

Celebrating excellence.

The Veterinary recordยท2026
Same journal

Get CMA compliant with new resources.

The Veterinary recordยท2026
Same journal

CVS Equine launches health and safety training.

The Veterinary recordยท2026
See all related articles

Related Experiment Video

Updated: May 4, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.3K

Suspected adverse events, 2012.

G Davis1, A Rooney, S Cooles

  • 1Suspected Adverse Reaction Surveillance Scheme, Veterinary Medicines Directorate, Woodham Lane, New Haw, Surrey KT15 3LS.

The Veterinary Record
|December 17, 2013
PubMed
Summary
This summary is machine-generated.

Veterinary pharmacovigilance surveillance identified an increase in serious adverse events and reports for products under the Small Animal Exemption Scheme, alongside a decrease in injection site reactions.

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

Related Experiment Videos

Last Updated: May 4, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.3K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

Area of Science:

  • Veterinary Medicine
  • Pharmacovigilance
  • Drug Safety Surveillance

Background:

  • The Veterinary Medicines Directorate (VMD) conducts pharmacovigilance to monitor the safety of animal medicines.
  • Surveillance data is crucial for identifying potential risks associated with veterinary drugs.

Purpose of the Study:

  • To summarize key findings from the VMD's pharmacovigilance unit's recent surveillance work.
  • To highlight trends in adverse event reporting for veterinary medicinal products.

Main Methods:

  • Analysis of reported adverse events submitted to the VMD pharmacovigilance unit.
  • Review of data specifically concerning products marketed under the Small Animal Exemption Scheme.
  • Categorization and trend analysis of different types of adverse reactions.

Main Results:

  • An observed increase in the number of serious adverse events reported.
  • A rise in adverse event reports associated with products available through the Small Animal Exemption Scheme.
  • A noted decrease in the incidence of injection site reactions.

Conclusions:

  • Pharmacovigilance surveillance is essential for detecting safety signals in veterinary medicines.
  • The VMD's ongoing monitoring highlights specific areas of concern and improvement in veterinary drug safety.
  • Continued vigilance is necessary to ensure the safe use of animal health products.